HomeACAD • NASDAQ
ACADIA Pharmaceuticals Inc
add
$25.33
3.26%
After Hours:(0.00%)0.00
$25.33
Closed: Aug 15, 5:43:25 PM UTC-4 · USD · NASDAQ · Disclaimer
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 264.57M | 9.34% |
Operating expense | 133.51M | 14.05% |
Net income | 26.67M | -20.14% |
Net profit margin | 10.08 | -26.96% |
Earnings per share | 0.16 | -20.00% |
EBITDA | 35.31M | 6.97% |
Effective tax rate | 33.68% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 762.00M | 52.11% |
Total assets | 1.23B | 34.07% |
Total liabilities | 403.17M | 1.45% |
Total equity | 822.38M | — |
Shares outstanding | 168.71M | — |
Price to book | 5.03 | — |
Return on assets | 6.86% | — |
Return on capital | 9.52% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 26.67M | -20.14% |
Cash from operations | 63.96M | 155.69% |
Cash from investing | -43.29M | 22.95% |
Cash from financing | 15.96M | 347.57% |
Net change in cash | 36.64M | 232.71% |
Free cash flow | 55.19M | 158.90% |
Previous close
$24.53
Day range
$24.53 - $25.39
Year range
$13.40 - $25.87
Market cap
4.27B USD
Avg Volume
1.79M
P/E ratio
19.06
Dividend yield
-
Primary exchange
NASDAQ
About
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Sorrento Valley, San Diego, California. Wikipedia
Founded
1993
Headquarters
Website
Employees
654
